Sana
Enterprise AI platform for integrating AI into company apps and knowledge.
Updated May 2026
Overview
- Website
- sanalabs.com
- Founded
- 2018
- Headquarters
- Stockholm, Sweden
- Posture
- Enterprise Search & Knowledge
Product overview
Sana is an AI company building the next generation of knowledge tools designed to bring AI into enterprise applications, internal knowledge bases, and company culture. Its platform enables organizations to seamlessly embed AI capabilities such as search, agents, and learning into their existing workflows and systems.
Revenue model
Subscription-based SaaS model for enterprise AI platform and services
Moat
- Patents/IP
- Proprietary Technology
- Regulatory Moat
Sana Biotechnology's primary competitive moat is its strong intellectual property portfolio around proprietary hypoimmune and fusogen platforms for cell and gene therapy, providing protection for innovations in oncology and genetic disorders. Additional strengths include foundational technologies, financial stability with $682.5 million in cash as of late 2024, and strategic partnerships, though these platforms remain preclinical and unproven.
Headwinds
High competition from established enterprise software vendors building similar AI integration capabilities.